Patent · US Active

Anti-ROR antibody constructs

US12084496B2 · kind B2 · utility

0Cited by
2References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2019
Grant dateSep 10, 2024
Priority date—
Expiry dateMay 21, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-ROR antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.